Zomig
Product Images NDC 68258-7103

6 FDA label images from Dispensing Solutions, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zomig (NDC 68258-7103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-7103-03 (Ndc 68258 7103 03 Astrazeneca)

Ndc 68258-7103-03 (Ndc 68258 7103 03       Astrazeneca)
Label for ZOMIG 5 mg tablets by Dispensing Solutions, Inc. The label shows 3 tablets per package with NDC 68258-7103-03 and product number 7Z0103. Each film-coated tablet contains 5 mg of zolmitriptan. The label includes dosage instructions and storage warnings.*
FDA Label Image

Figure Four (Zomig Figfive)

Figure Four (Zomig Figfive)
A line graph comparing the estimated probability of remediation or rescue over 24 hours from the initial dose between placebo and ZOMIG-ZMT 2.5 mg. The graph shows the probability on the vertical axis and time in hours on the horizontal axis, illustrating a higher probability for ZOMIG-ZMT compared to placebo.*
FDA Label Image

Figure Three (Zomig Figfour)

Figure Three (Zomig Figfour)
A line graph showing the estimated probability of response over time from the initial dose, comparing ZOMIG-ZMT 2.5 MG with placebo. The X-axis represents time intervals from 0 to 2 hours, and the Y-axis shows the probability of response from 0% to 100%. ZOMIG-ZMT 2.5 MG demonstrates a higher probability of response at each time point compared to placebo.*
FDA Label Image

Chemical Structure (Zomig Figone)

Chemical Structure (Zomig Figone)
Chemical structure of the active ingredient in ZOMIG, showing a bicyclic indole core with an ether-linked methyl group, a ketone group, and a dimethylaminoethyl side chain.*
FDA Label Image

Figure Two (Zomig Figthree)

Figure Two (Zomig Figthree)
A line graph depicting the estimated probability of remediation or rescue over 24 hours from the initial dose, comparing Placebo, 1 mg, 2.5 mg, and 5 mg dosages. The y-axis shows percentage probability from 0% to 100%, and the x-axis shows time in hours from 0 to 24. Different line styles represent each dosage group.*
FDA Label Image

Figure One (Zomig Figtwo)

Figure One (Zomig Figtwo)
A line graph depicting the estimated probability of response over time from the initial dose, comparing placebo with ZOMIG at 1 mg, 2.5 mg, and 5 mg doses. The X-axis represents time in hours (0 to 4 hours), and the Y-axis shows the estimated probability of response in percentage (0% to 100%). The ZOMIG doses generally show higher response probabilities compared to placebo over the 4-hour period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.